Janux Therapeutics, Inc. (JANX) Tops Q4 EPS by 11c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q4 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Trump: Walmart will be lowering prices
• Pennon Group Plc. (PNN:LN) (PEGRF) PT Lowered to GBP6 at BofA Securities
• RBC Capital Starts Jeronimo Martins SGPS SA (JMT:PL) (JRONF) at Outperform